138 related articles for article (PubMed ID: 3928726)
1. Amiodarone in the treatment of life-threatening ventricular tachycardia: role of Holter monitoring in predicting long-term clinical efficacy.
Veltri EP; Reid PR; Platia EV; Griffith LS
J Am Coll Cardiol; 1985 Oct; 6(4):806-13. PubMed ID: 3928726
[TBL] [Abstract][Full Text] [Related]
2. Utility of ambulatory electrocardiographic monitoring for predicting recurrence of sustained ventricular tachyarrhythmias in patients receiving amiodarone.
Sokoloff NM; Spielman SR; Greenspan AM; Rae AP; Brady PM; Kay HR; Horowitz LN
J Am Coll Cardiol; 1986 Apr; 7(4):938-41. PubMed ID: 3958353
[TBL] [Abstract][Full Text] [Related]
3. The use of ambulatory monitoring in the prognostic evaluation of patients with sustained ventricular tachycardia treated with amiodarone.
Veltri EP; Griffith LS; Platia EV; Guarnieri T; Reid PR
Circulation; 1986 Nov; 74(5):1054-60. PubMed ID: 3769165
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of malignant ventricular tachyarrhythmia with amiodarone: comparison of empirical administration and administration guided by Holter or ventricular stimulation. Results of the parallel test].
Raviele A; Di Pede F; Gasparini G; Zanocco A; Delise P; Bonso A; D'Este D; Piccolo E
G Ital Cardiol; 1991 Mar; 21(3):259-69. PubMed ID: 1894120
[TBL] [Abstract][Full Text] [Related]
5. Value of Holter monitoring in identifying risk for sustained ventricular arrhythmia recurrence on amiodarone.
Marchlinski FE; Buxton AE; Flores BT; Doherty JU; Waxman HL; Josephson ME
Am J Cardiol; 1985 Mar; 55(6):709-12. PubMed ID: 3976513
[TBL] [Abstract][Full Text] [Related]
6. Value of Holter monitoring in predicting long-term efficacy and inefficacy of amiodarone used alone and in combination with class 1A antiarrhythmic agents in patients with ventricular tachycardia.
Kim SG; Felder SD; Figura I; Johnston DR; Waspe LE; Fisher JD
J Am Coll Cardiol; 1987 Jan; 9(1):169-74. PubMed ID: 3794093
[TBL] [Abstract][Full Text] [Related]
7. Comparison of programmed stimulation and Holter monitoring for predicting long-term efficacy and inefficacy of amiodarone used alone or in combination with a class 1A antiarrhythmic agent in patients with ventricular tachyarrhythmia.
Kim SG; Felder SD; Figura I; Johnston DR; Waspe LE; Fisher JD
J Am Coll Cardiol; 1987 Feb; 9(2):398-404. PubMed ID: 3805529
[TBL] [Abstract][Full Text] [Related]
8. Amiodarone in refractory life-threatening ventricular arrhythmias.
Nademanee K; Singh BN; Hendrickson J; Intarachot V; Lopez B; Feld G; Cannom DS; Weiss JL
Ann Intern Med; 1983 May; 98(5 Pt 1):577-84. PubMed ID: 6846970
[TBL] [Abstract][Full Text] [Related]
9. Long term-treatment of ventricular tachycardia in ambulatory patients with amiodarone.
Vazquez Blanco M; Milei J; Piñeiro DJ; Buceta JE; Dreyer MP
Acta Cardiol; 1983; 38(2):125-32. PubMed ID: 6603085
[TBL] [Abstract][Full Text] [Related]
10. Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia.
Veltri EP; Reid PR; Platia EV; Griffith LS
Am J Cardiol; 1985 Feb; 55(4):375-9. PubMed ID: 3969872
[TBL] [Abstract][Full Text] [Related]
11. Management of refractory sustained ventricular tachycardia with amiodarone: a reappraisal.
Lavery D; Saksena S
Am Heart J; 1987 Jan; 113(1):49-56. PubMed ID: 3799441
[TBL] [Abstract][Full Text] [Related]
12. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia.
McKenna WJ; Oakley CM; Krikler DM; Goodwin JF
Br Heart J; 1985 Apr; 53(4):412-6. PubMed ID: 4039188
[TBL] [Abstract][Full Text] [Related]
13. [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
Ventosa A; Adragão P; Bonhorst D; Seabra-Gomes R
Rev Port Cardiol; 1990 Jan; 9(1):33-9. PubMed ID: 1691653
[TBL] [Abstract][Full Text] [Related]
14. Amiodarone: risk factors for recurrence of symptomatic ventricular tachycardia identified at electrophysiologic study.
Naccarelli GV; Fineberg NS; Zipes DP; Heger JJ; Duncan G; Prystowsky EN
J Am Coll Cardiol; 1985 Oct; 6(4):814-21. PubMed ID: 3928727
[TBL] [Abstract][Full Text] [Related]
15. Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone.
McGovern B; Garan H; Malacoff RF; DiMarco JP; Grant G; Sellers TD; Ruskin JN
Am J Cardiol; 1984 Jun; 53(11):1558-63. PubMed ID: 6731300
[TBL] [Abstract][Full Text] [Related]
16. [Prediction of long-term efficacy of amiodarone for refractory ventricular tachycardia: clinical significance of electrophysiologic study and Holter monitoring].
Tsuchiya M; Kasanuki H; Ohnishi S; Hosoda S
J Cardiol; 1996 Nov; 28(5):267-76. PubMed ID: 8953400
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of amiodarone during long-term treatment of malignant ventricular arrhythmias in patients with chronic chagasic myocarditis.
Chiale PA; Halpern MS; Nau GJ; Tambussi AM; Przybylski J; Lázzari JO; Elizari MV; Rosenbaum MB
Am Heart J; 1984 Apr; 107(4):656-65. PubMed ID: 6702559
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of Holter monitoring in predicting efficacy of amiodarone therapy for sustained ventricular tachycardia associated with coronary artery disease.
Nasir N; Doyle TK; Wheeler SH; Pacifico A
Am J Cardiol; 1994 Mar; 73(8):554-8. PubMed ID: 7511872
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of amiodarone during long-term treatment of potentially dangerous ventricular arrhythmias in patients with chronic stable ischemic heart disease.
Kaski JC; Girotti LA; Elizari MV; Lázzari JO; Goldbarg A; Tambussi A; Rosenbaum MB
Am Heart J; 1984 Apr; 107(4):648-55. PubMed ID: 6702558
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of early electrophysiologic studies for ventricular tachycardia recurrence in patients with coronary artery disease treated with amiodarone.
Manolis AS; Uricchio F; Estes NA
Am J Cardiol; 1989 May; 63(15):1052-7. PubMed ID: 2705375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
